Suppression of type I collagen production by microRNA-29b in cultured human stellate cells

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 316-321

  Ogawa, Tomohiro ^a   Iizuka, Masashi ^a   Sekiya, Yumiko ^a,b   Yoshizato, Katsutoshi ^a,c   Ikeda, Kazuo ^d   Kawada, Norifumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

^c PhoenixBio USA Corporation   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Interferon; Liver fibrosis; SP1; TargetScan; TGF

Indexed keywords

ALPHA INTERFERON; COLLAGEN TYPE 1; MESSENGER RNA; MICRORNA; MICRORNA 143; MICRORNA 218; MICRORNA 29B; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL ACTIVATION; CELL CULTURE; FIBROGENESIS; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER; LIVER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL;

3' UNTRANSLATED REGIONS; CELLS, CULTURED; COLLAGEN TYPE I; GENE EXPRESSION REGULATION; HEPATIC STELLATE CELLS; HUMANS; INTERFERON-ALPHA; MICRORNAS; SP1 TRANSCRIPTION FACTOR;

EID: 72949109956     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.056     Document Type: Article

References (30)

1. Bataller R., and Brenner D.A. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21 (2001) 437-451
2. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275 (2000) 2247-2250
3. Kawada N. The hepatic perisinusoidal stellate cell. Histol. Histopathol. 12 (1997) 1069-1080
4. Dooley S., Delvoux B., Lahme B., Mangasser-Stephan K., and Gressner A.M. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31 (2000) 1094-1106
5. Albanis E., and Friedman S.L. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin. Liver Dis. 5 (2001) 315-334 v-vi
6. Filipowicz W., Bhattacharyya S.N., and Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 9 (2008) 102-114
7. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
8. Brennecke J., Hipfner D.R., Stark A., Russell R.B., and Cohen S.M. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113 (2003) 25-36
9. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., and Greenberg M.E. A brain-specific microRNA regulates dendritic spine development. Nature 439 (2006) 283-289
10. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004) 83-86
11. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., Chang T.C., Vivekanandan P., Torbenson M., Clark K.R., Mendell J.R., and Mendell J.T. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137 (2009) 1005-1017
12. Chen J.F., Murchison E.P., Tang R., Callis T.E., Tatsuguchi M., Deng Z., Rojas M., Hammond S.M., Schneider M.D., Selzman C.H., Meissner G., Patterson C., Hannon G.J., and Wang D.Z. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. USA 105 (2008) 2111-2116
13. Perkins D.O., Jeffries C.D., Jarskog L.F., Thomson J.M., Woods K., Newman M.A., Parker J.S., Jin J., and Hammond S.M. MicroRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol. 8 (2007) R27
14. Pedersen I.M., Cheng G., Wieland S., Volinia S., Croce C.M., Chisari F.V., and David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449 (2007) 919-922
15. Ji J., Shi J., Budhu A., Yu Z., Forgues M., Roessler S., Ambs S., Chen Y., Meltzer P.S., Croce C.M., Qin L.X., Man K., Lo C.M., Lee J., Ng I.O., Fan J., Tang Z.Y., Sun H.C., and Wang X.W. MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 361 (2009) 1437-1447
16. Rogler C.E., Levoci L., Ader T., Massimi A., Tchaikovskaya T., Norel R., and Rogler L.E. MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology 50 (2009) 575-584
17. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., and Monia B.P. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3 (2006) 87-98
18. L. Zheng, G.C. Lv, J. Sheng, Y.D. Yang, Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD, J. Gastroenterol. Hepatol. (2009).
19. Ji J., Zhang J., Huang G., Qian J., Wang X., and Mei S. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett. 583 (2009) 759-766
20. Guo C.J., Pan Q., Li D.G., Sun H., and Liu B.W. MiR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J. Hepatol. 50 (2009) 766-778
21. Shiratori Y., Imazeki F., Moriyama M., Yano M., Arakawa Y., Yokosuka O., Kuroki T., Nishiguchi S., Sata M., Yamada G., Fujiyama S., Yoshida H., and Omata M. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann. Intern. Med. 132 (2000) 517-524
22. Poynard T., McHutchison J., Davis G.L., Esteban-Mur R., Goodman Z., Bedossa P., and Albrecht J. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 32 (2000) 1131-1137
23. Inagaki Y., Nemoto T., Kushida M., Sheng Y., Higashi K., Ikeda K., Kawada N., Shirasaki F., Takehara K., Sugiyama K., Fujii M., Yamauchi H., Nakao A., De Crombrugghe B., Watanabe T., and Okazaki I. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 38 (2003) 890-899
24. Xu L., Hui A.Y., Albanis E., Arthur M.J., O'Byrne S.M., Blaner W.S., Mukherjee P., Friedman S.L., and Eng F.J. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54 (2005) 142-151
25. Otogawa K., Ogawa T., Shiga R., Nakatani K., Ikeda K., Nakajima Y., and Kawada N. Attenuation of acute and chronic liver injury in rats by iron-deficient diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R311-R320
26. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J.J., and Natarajan R. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. USA 104 (2007) 3432-3437
27. Li L., Artlett C.M., Jimenez S.A., Hall D.J., and Varga J. Positive regulation of human alpha 1 (I) collagen promoter activity by transcription factor Sp1. Gene 164 (1995) 229-234
28. Garcia-Ruiz I., de la Torre P., Diaz T., Esteban E., Fernandez I., Munoz-Yague T., and Solis-Herruzo J.A. Sp1 and Sp3 transcription factors mediate malondialdehyde-induced collagen alpha 1 (I) gene expression in cultured hepatic stellate cells. J. Biol. Chem. 277 (2002) 30551-30558
29. Sysa P., Potter J.J., Liu X., and Mezey E. Transforming growth factor-beta1 up-regulation of human alpha(1) (I) collagen is mediated by Sp1 and Smad2 transacting factors. DNA Cell Biol. 28 (2009) 425-434
30. van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., Hill J.A., and Olson E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 105 (2008) 13027-13032